Skip to content
The Kids Research Institute Australia logo
Donate

No results yet

Search

Research

Prediction models for the development of COPD: A systematic review

We aimed to systematically review and assess the performance of all published models that predicted development of COPD

Research

Prenatal omega-3 LCPUFA and symptoms of allergic disease and sensitization throughout early childhood

Maternal supplementation with 900 mg of ω-3 LCPUFA did not change the progression of IgE-mediated allergic disease symptoms or sensitization

Research

Topical antibiotics for chronic suppurative otitis media

To assess the effects of topical antibiotics for people with chronic suppurative otitis media.

Research

The Ultra-High-Risk for psychosis groups: Evidence to maintain the status quo

Our findings demonstrate that Ultra-High-Risk groups evidence a similar clinical risk profile when we expand this beyond transition to psychosis

Research

Autism and psychosis: Clinical implications for depression and suicide

This study examines the association of autism spectrum traits, depressive symptoms and suicidal behaviour in individuals with psychotic experiences

Research

Incidental inequity

Reporting incidental genomic findings requires various considerations. One of these is that 'the clinical validity and utility of variants should be known'.

Research

Perinatal risk factors associated with skin infection hospitalisation in Western Australian Aboriginal and Non-Aboriginal children

We have quantified the relative influence of perinatal risk factors associated with skin infection hospitalisations in WA children

Research

A preliminary investigation of the effects of prenatal alcohol exposure on facial morphology in children with Autism Spectrum Disorder

While early exposure to alcohol may influence the development of facial structures, it does not appear to be associated with ASD phenotypic variability

Research

A population pharmacokinetic study of benzathine benzylpenicillin G administration in children and adolescents with rheumatic heart disease

Few children and adolescents receiving BPG as secondary prophylaxis will achieve concentrations >0.02 mg/L for the majority of the time between injections